Psychotherapists' openness to engage their patients in Psilocybin-Assisted Therapy for mental health treatment
Authors:
- 17 December 2022
- journal article
- research article
- Published by Elsevier in Journal of Affective Disorders
- Vol. 323, 748-754
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- Psilocybin-Occasioned Mystical Experiences in the Treatment of Tobacco AddictionCurrent Drug Abuse Reviews, 2015
- Psilocybin-assisted treatment for alcohol dependence: A proof-of-concept studyJournal of Psychopharmacology, 2015
- Safety and Efficacy of Lysergic Acid Diethylamide-Assisted Psychotherapy for Anxiety Associated With Life-threatening DiseasesJournal of Nervous & Mental Disease, 2014
- Effects of Schedule I drug laws on neuroscience research and treatment innovationNature Reviews Neuroscience, 2013
- Mystical-type experiences occasioned by psilocybin mediate the attribution of personal meaning and spiritual significance 14 months laterJournal of Psychopharmacology, 2008
- Mediators and Mechanisms of Change in Psychotherapy ResearchAnnual Review of Clinical Psychology, 2007
- Residential Psychedelic (LSD) Therapy for the Narcotic AddictArchives of General Psychiatry, 1973
- The Cyclic PsychedelicsAmerican Journal of Psychiatry, 1968
- Lysergic Acid Diethylamide (LSD-25) as a Facilitating Agent in PsychotherapyArchives of General Psychiatry, 1960
- PSYCHOTHERAPY WITH LYSERGIC ACID DIETHYLAMIDEJournal of Nervous & Mental Disease, 1958